How to secure upstream pharmaceutical supply chain risks with data and advanced technologies to increase access to quality medical products for patients
While the global vaccination effort to curb the spread of COVID-19 continues to ramp up worldwide, access to COVID-19 vaccines, particularly in low- and middle-income countries, remains staggeringly low. In fact, low- and middle-income countries received less than one percent of available doses.
Universal health coverage requires access to quality-assured medicines. Unfortunately, substandard and falsified medicines are highly preval
When a problem puts millions of lives at risk, costs economies billions of dollars and undermines decades of hard-earned health progress, it deserves prompt and strategic attention. I’m describing the consequences of poor-quality medicines – a worldwide problem that deserves worldwide attention.
As government agencies consider solutions to the growing opioid crisis, the Food and Drug Administration (FDA) recently sought public comment about ways to best address this national emergency.
Countries throughout Africa are working to harmonize standards to make processes more efficient and help bring needed pharmaceuticals to market, while protecting medicines quality. Learn more
Show 11 More